COVID-19 vaccine: Pfizer-BioNTech eye $26 bn revenue, Moderna estimates $19.2 bn sales in 2021
The two m-RNA technology based COVID-19 vaccines are set to shatter the record of Pfizer's Lipitor in terms of highest sales in a year.08-05-2021
08-05-2021
Pfizer lifts Covid-19 vaccine production targets for 2021, 2022
Drugmaker's raised goal comes as India and other developing countries clamor for more doses08-05-2021
Chinese COVID-19 vaccine Sinopharm gets WHO approval for emergency use
While WHO has listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen vaccines for emergency use, the Chinese vaccine got delayed recognition due to data related issues08-05-2021
Pfizer-BioNTech vaccine is highly effective against variants, studies find
Previous research suggested that B.1.1.7 is more infectious and more deadly than other variants, but that vaccines still worked well against it07-05-2021
Covid-19 vaccine: Germany says patent protection 'must remain'
Pfizer CEO Albert Bourla meanwhile told AFP his company was 'not at all' in favor of the measure07-05-2021
Pfizer-BioNTech can supply 3 billion vaccine doses this year
As demand soars for messenger RNA Covid vaccines -- a new technology that has become a mainstay of the immunization effort -- Pfizer and BioNTech have repeatedly bumped up their production goals .The partners had said in March they could make 2.5 billion doses of their two-shot vaccine this year06-05-2021
Assured India no safety concerns with COVID-19 vaccine: Pfizer
Pfizer said it is holding fresh talks with the government after having withdrawn its initial application in February over the earlier local trial rule04-05-2021
WHO gives emergency use listing to Moderna's coronavirus vaccine
The World Health Organisation has given the go-ahead for emergency use of Moderna's COVID-19 vaccine. The mRNA vaccine from the US manufacturer joins vaccines from AstraZeneca, Pfizer-BioNTech and Johnson & Johnson in receiving the WHO's emergency use listing. Similar approvals for China's Sinopharm and Sinovac vaccines are expected in the coming days and weeks, WHO has said. The greenlight for Moderna's vaccine, announced late Friday, took many months because of delays that WHO faced in getting data from the manufacturer. Many countries without their own advanced medical regulatory and assessment offices rely on the WHO listing to decide whether to use vaccines. UN children's agency UNICEF also uses the listing to deploy vaccines in an emergency like the pandemic. The announcement, however, wasn't likely to have an immediate impact on supplies of Moderna's vaccine for the developing world. The company struck supply agreements with many rich countries, which will have already...01-05-2021
BioNTech eyes vaccine for 12-15 year olds in Europe from June
BioNTech said on Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.29-04-2021
Top US senators ask Pfizer, Moderna, JJ for global access to vaccines, including in India
"COVID-19 has infected over 148 million people and killed over three million globally, with hundreds of thousands of new cases and thousands of deaths being reported daily," the five senators wrote in identical letters to the CEOs of Pfizer, Moderna and Johnson Johnson on Wednesday.29-04-2021